Procainamide-induced systemic lupus erythematosus. 1968

B D Rutherford

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011342 Procainamide A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B D Rutherford
May 1973, Rheumatology and rehabilitation,
B D Rutherford
February 1969, Proceedings of the Royal Society of Medicine,
B D Rutherford
July 1971, Military medicine,
B D Rutherford
May 1970, Annals of the rheumatic diseases,
B D Rutherford
May 1977, Journal of the American Geriatrics Society,
B D Rutherford
August 1972, The Medical journal of Australia,
B D Rutherford
March 1974, South Dakota journal of medicine,
B D Rutherford
December 1962, The New England journal of medicine,
B D Rutherford
October 1980, Harefuah,
B D Rutherford
January 1978, Clinical orthopaedics and related research,
Copied contents to your clipboard!